IMS offers leading-edge consulting services to the biosciences industry
In recent years, the biotechnology sector has been the growth driver for healthcare across the globe. Often being the instigator of innovative products, the industry faces the challenges of capitalising on its research and ensuring an optimal return on investment that satisfies its investors and business owners.
Biotechnology companies, being smaller than traditional pharmaceutical manufacturers and focused on specialist products, often need help in defining a new market and creating a positioning and marketing strategy that will ensure high penetration. Being entrenched in the science, the biotech sector sometimes needs the input of partners with more commercial experience and a bigger marketing presence in order to ensure success in the marketplace.
Hence, some of the key issues they face are:
- Identifying the most appropriate opportunities in relation to innovative technologies
- Assessing and measuring the commercial value of each opportunity
- Identifying the strategic approach that will achieve maximum revenue (partnering, licensing etc)
- Determining which organisations are the best candidates to implement an identified strategic approach
- Evaluate the likely impact of a molecule within the marketplace and the way it will change therapy area dynamics
IMS offers advisory and support services specifically directed at the biotechnology sector, including:
- Licensing and partnering evaluation
- Pipeline and technology assessment and valuation
- Deal benchmarking and negotiations support
- Commercialisation of the emerging pipeline